🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects and best dose of sirolimus w...
Status
Completed
Location
VA Puget Sound Health Care System
Start Date
2013-10
Trial ID
NCT01938573
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
Purpose of this study is to determine appropriate dosing of ABI-009 and eva...
Status
Completed
Location
Columbia University Medical Center
Start Date
2014-04-09
Trial ID
NCT02009332
Treatments Being Tested
This pilot phase I trial studies the side effects and best way to give siro...
Status
Completed
Location
Mayo Clinic
Start Date
2013-09
Trial ID
NCT01888302
Treatments Being Tested
Multicenter and prospective phase II trial with gemcitabine and rapamycin i...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT02429973
Treatments Being Tested
This phase I/II trial is studying the side effects and best dose of everoli...
Status
Completed
Location
University of Colorado at Denver Health Sciences Center
Start Date
2009-08
Trial ID
NCT00981162
RATIONALE: Treating tumor tissue in the laboratory with different drugs may...
Status
Terminated
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2005-10
Trial ID
NCT00276744
RATIONALE: Drugs used in chemotherapy, such as gemcitabine hydrochloride an...
Status
Completed
Location
Leeds Cancer Centre at St. James's University Hospital
Start Date
2008-02
Trial ID
NCT01090466
Treatments Being Tested
This is an open-label, randomized trial in relapsed refractory subjects wit...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-05
Trial ID
NCT00117598
Treatments Being Tested
This is a Phase 1B/2, non-randomized, dose-escalation, multicenter, open-la...
Status
Terminated
Location
Multiple Locations
Start Date
2009-09-25
Trial ID
NCT00954512